Analysis of Discrepancies in Drug Indications Approved by the US FDA, Health Canada and the European Medicines Agency

4152.0
Time for international harmonization?: US FDA, Health Canada and the European Medicines Agency

Tuesday, November 3, 2015: 10:30 a.m. - 12:00 p.m.

Oral

Moderator:

Enrique Seoane-Vazquez, Ph.D.

10:30am

10:50am

Analysis of Trends in Utilization and Cost of Insulins in Canada and the US
Stefan Dimario, PharmD, Enrique Seoane-Vazquez, Ph.D., Tewodros Eguale, MD and Benard Tyrell

11:10am

Giving providers access to formulary drug cost information - association with patients' drug costs and medication use
Chien-Wen Tseng, MD MPH, Deborah Juarez, ScD, Grace Lin, MD MAS, James Davis, PhD, Jinoos Yazdany, MD MPH, Qimei He, PhD, Allison Imamura, Chen Randi, MS and Adams Dudley, MD MBA

11:30am

Analysis of Discrepancies in Drug Indications Approved by the US FDA, Health Canada and the European Medicines Agency
Enrique Seoane-Vazquez, Ph.D., Tewodros Eguale, MD, Rosa Rodriguez-Monguio, PhD, MS, Kholoud Ghazawi and Gordon Schiff, MD

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Medical Care Section
Endorsed by: International Health, APHA-Committee on Women's Rights

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)

See more of: Medical Care Section